Background Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disease ranging from
simple hepatic steatosis (NAFL) to non-alcoholic steatohepatitis (NASH) which may …

Liver cancer is the fourth leading cause of cancer deaths globally, of which hepatocellular
carcinoma (HCC) is the major subtype. Viral hepatitis B and C infections, alcohol abuse, and …

Nonalcoholic fatty liver disease (NAFLD) represents a spectrum of conditions ranging from
simple steatosis (NAFL), over nonalcoholic steatohepatitis (NASH) with or without fibrosis, to …

Non-alcoholic fatty liver disease (NAFLD) is a multifaceted metabolic disorder, whose
spectrum covers clinical, histological and pathophysiological developments ranging from …

Nonalcoholic steatohepatitis (NASH) is the main cause of chronic liver disease in the
Western world and a major health problem, owing to its close association with obesity …

Simple Summary Hepatocellular carcinoma (HCC) is one of the most frequently occurring
cancers, and the prognosis for late-stage HCC remains poor. A better understanding of the …

Background & Aims microRNAs (miRNAs) are deregulated in non-alcoholic fatty liver
disease (NAFLD) and have been proposed as useful markers for the diagnosis and …

Genetics and epigenetics play a key role in the development of several diseases, including
nonalcoholic fatty liver disease (NAFLD). Family studies demonstrate that first degree …

Nonalcoholic fatty liver disease (NAFLD) defines a wide pathological spectrum ranging from
simple steatosis to nonalcoholic steatohepatitis (NASH) which may predispose to liver …

MicroRNAs (miRNAs) are small non-coding RNAs that regulate multiple physiological and
pathological functions through the modulation of gene expression at the post-transcriptional …